INSIGHTS ON CELL & GENE THERAPY LOGISTICS

  • Catalent Biologics
    Catalent Biologics

    Catalent Biologics is your one integrated partner with expertise to get your biologic to market faster. We have the passion to help you accelerate, simplify and de-risk your next biologic from development and manufacturing, to fill/finish, clinical supply and commercial launch.

  • Catalent Clinical Supply Services
    Catalent Clinical Supply Services

    Whether you have a large, complex global study or need a small, regional solution, we can reliably supply your clinical trial anywhere in the world. From Phase I to Phase III and beyond, we are the catalyst for your success.

  • Transforming Next-Gen Therapy Supply Chains Into Patient-Connected Value Chains
    Transforming Next-Gen Therapy Supply Chains Into Patient-Connected Value Chains

    Cell, gene, and other emerging therapies are distinctly different from traditional biopharma products. Every lot is for a named patient or small population of patients, and that lot drives direct uplift on the bottom line. Traditional supply chain management does not necessarily create patient value in emerging therapy value chains. Operations should be the backbone of a distribution model that delivers these products efficiently and effectively over the last few yards.

  • Managing Risks To Time Critical Product Imports At Clinical Supply Depots
    Managing Risks To Time Critical Product Imports At Clinical Supply Depots

    Global regulatory standards for clinical trials are, simply put, complex. In this case study, learn how one company worked with its partner to overcome the challenge of a protocol based in the US, an investigational medical product (IMP) approved in the EU, and varying QP (qualified person) rules from country to country, to conduct their clinical trial in Isreal.

  • Innovative Clinical Supply Solutions - Cold Chain
    Innovative Clinical Supply Solutions - Cold Chain

    With our team of packaging experts and extensive cold chain capabilities, this case study discusses the creation a custom packaging and distribution solution to meet this client’s unique needs. Through our partnership, the product was successfully packaged in sufficient quantity and on time for the Phase I trial.

  • Single-Use Systems For Shipping Frozen Drug Materials – Every Component Counts
    Single-Use Systems For Shipping Frozen Drug Materials – Every Component Counts

    Integrated single-use freeze-thaw assemblies with reliable component parts, such as the connectors supplied by CPC, have become the primary implementation choice for achieving successful drug substance transfers between manufacturing facilities.

  • Single-Use Systems For Storing And Shipping Frozen Drug Materials
    Single-Use Systems For Storing And Shipping Frozen Drug Materials

    The logistics of decoupling drug substance manufacturing from final drug product formulation is now possible using integrated single-use freeze-thaw assemblies which incorporate reliable components.

  • Manufacturing Facility Will Meet Needs Of Cell & Gene Trials
    Manufacturing Facility Will Meet Needs Of Cell & Gene Trials

    Abeona Therapeutics is developing investigational gene and cell therapies for people living with serious and rare diseases. Last year, Abeona held a ribbon-cutting ceremony to celebrate the groundbreaking of a manufacturing facility that is one year later producing gene therapy material for their clinical and pre-clinical programs. As is the norm with gene therapy, Abeona uses a virus as vehicles to deliver functional copies of defective genes.

  • Refrigerated Transport For Gene Therapies: Exploring The Pros And Cons
    Refrigerated Transport For Gene Therapies: Exploring The Pros And Cons

    In the first part of this two-part article, common cryogenic shipping methods for gene therapy products were presented, and pros and cons of each method were discussed. In this part, major refrigerated transport methods of gene therapy intermediates will be addressed.

  • Cell Therapy Manufacturing: The Supply Chain Challenge
    Cell Therapy Manufacturing: The Supply Chain Challenge

    Overcoming the challenges of manufacturing and administering a complex product to any patient is critical for delivering cell therapies. Two industry experts detail strategies to meet supply chain challenges.

More On Therapy Logistics